EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Advanced microbiome therapeutics as a novel modality for oral delivery of peptides to manage metabolic diseases

Ruben Vazquez-Uribe, Karl Alex Hedin, Tine Rask Licht, Max Nieuwdorp, Morten O A Sommer

Trends in Endocrinology & Metabolism · 2025

DOI: 10.1016/j.tem.2024.04.021 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Endocrinology & Metabolism, 2025. Verfasst von Ruben Vazquez-Uribe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kgs. Lyngby, Denmark. Hauptthemen laut MEDLINE: Metabolic Diseases, Peptides. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Novo Nordisk Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic DiseasesPeptidesHumansAnimalsAdministration, OralMicrobiotaGastrointestinal MicrobiomeDiabetes Mellitus, Type 2

Stichwörter der Autor:innen

MASLDadvanced microbiome therapeuticsdiabetesmetabolic diseasesobesity

Substanzen

Peptides

Autor:innen und Institutionen

  • Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kgs. Lyngby, Denmark.
  • National Food Institute, Technical University of Denmark, Kgs. Lyngby, Denmark.
  • Departments of Internal and Experimental Vascular Medicine, Amsterdam University Medical Centers, Location AMC, Amsterdam, The Netherlands.
  • Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kgs. Lyngby, Denmark. Electronic address: msom@bio.dtu.dk.

Förderung

  • Novo Nordisk Foundation

Zitieren

APA

Vazquez-Uribe, R., Hedin, K. A., Licht, T. R., Nieuwdorp, M., & Sommer, M. O. A. (2025). Advanced microbiome therapeutics as a novel modality for oral delivery of peptides to manage metabolic diseases. Trends in Endocrinology & Metabolism. https://doi.org/10.1016/j.tem.2024.04.021

Vancouver

Vazquez-Uribe R, Hedin KA, Licht TR, Nieuwdorp M, Sommer MOA. Advanced microbiome therapeutics as a novel modality for oral delivery of peptides to manage metabolic diseases. Trends in Endocrinology & Metabolism. 2025. doi:10.1016/j.tem.2024.04.021

BibTeX
@article{VazquezUribe2025,
  author = {Vazquez-Uribe, Ruben and Hedin, Karl Alex and Licht, Tine Rask and Nieuwdorp, Max and Sommer, Morten O A},
  title = {Advanced microbiome therapeutics as a novel modality for oral delivery of peptides to manage metabolic diseases},
  journal = {Trends in Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1016/j.tem.2024.04.021}
}
Kostenlos starten →